Lining up liquidity, figuring out the federal stimulus packages
We checked in again with Eric Jordahl, a capital markets expert at Kaufman Hall, about what healthcare CFOs may be working on amid the COVID-19 epidemic and the economic consequences of social distancing. Jordahl told us a little over a week ago that CFOs were contacting their relationship banks, seeking lines of credit or making plans to do so depending on their organizations' short-term liquidity needs. Here is what he had to say:
That work is continuing. Banks are getting inundated with requests, not just from healthcare but pretty much every segment of the economy is trying to do the same thing - the lining up of liquidity. I think the primary level of external liquidity formation is ongoing.
The second thing that has come out is the federal stimulus packages. I think finance teams are busy trying to understand two things. The first is, what kind of dollars might those generate for their organizations? And when might they use those dollars for liquidity purposes.
[Consider the advanced payment mechanism.] Basically, the way that works is you have to start repaying it after a certain amount of time so it is an advance on things. If [the repayment] is a certain number of days after you start utilizing it, when do you sequence that? That is the kind of thinking going on.
Related: This Week in the C-Suite
The third part is trying to put in place financial forecasting models that might be able to help describe on a rolling basis what changing liquidity needs will look like.
If all of this magically clears out in a month, that is going to produce one level of liquidity issues.
If this goes on for six months, it is a whole other thing. So trying to understand the different scenarios, what the liquidity gaps look like going forward are paramount.
I don’t think there is such great modeling out there because there is so much uncertainty.
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with CeCi Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
What States are Doing to Regulate Pharmacy Benefit Managers
March 26th 2024In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers found that state-level PBM reform focused on more transparent drug pricing, better patient access to prescription drugs, and more stringent auditing and reporting requirements.
Read More